Dow Up0.25% Nasdaq Up0.65%

Ligand Pharmaceuticals Incorporated (LGND)

-NGM
122.81 Up 0.85(0.70%) May 27, 4:00PM EDT
|After Hours : 122.83 Up 0.02 (0.02%) May 27, 4:25PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Net Income 6,608   8,448   224,539   23,564  
Operating Activities, Cash Flows Provided By or Used In
Depreciation5,563  3,226  3,339  3,163  
Adjustments To Net Income10,008  2,720  (216,038)(16,971)
Changes In Accounts Receivables(5,604)(653)40  1,891  
Changes In Liabilities(4,289)(1,143)(1,894)1,533  
Changes In Inventories853  (243)375  (383)
Changes In Other Operating Activities(25)1,310  76  (1,214)
Total Cash Flow From Operating Activities 13,114   13,665   10,437   10,046  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(238)(66) -  (17)
Investments18,779  (9,611)(25,087)(67,513)
Other Cash flows from Investing Activities(98,301)(1,800)(1,278)(4,693)
Total Cash Flows From Investing Activities (79,760) (11,477) (26,365) (72,223)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock511  1,470  1,460  4,649  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 511   1,470   1,460   4,649  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents (66,135) 3,658   (14,468) (57,528)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.